Proprotein convertase subtilisin/kexin type 9 (PCSK9) enhances colon cancer progression by modulating epithelial-mesenchymal transition (EMT) and PI3K/AKT signaling while skewing macrophage polarization (175). This evidence concerns the gene PCSK9 and malignant colon neoplasm.